Scarica l'app Stockscreener
7.17
2.43%
0.17
Dopo l'orario di chiusura:
7.31
0.14
+1.95%
Precedente Chiudi:
$7.00
Aprire:
$7.07
Volume 24 ore:
62,015
Relative Volume:
0.60
Capitalizzazione di mercato:
$249.06M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-3.6241
EPS:
-1.9784
Flusso di cassa netto:
-
1 W Prestazione:
-1.38%
1M Prestazione:
+15.65%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$6.875
$7.64
Intervallo di 1 settimana:
$6.795
$8.00
Portata 52W:
$5.25
$8.79
Anteris Technologies Global Corp Stock (AVR) Company Profile
Nome
Anteris Technologies Global Corp
Settore
Industria
Telefono
-
Indirizzo
-
Confronta AVR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVR
Anteris Technologies Global Corp
|
7.17 | 249.06M | 0 | 0 | 0 | -1.9784 |
|
ISRG
Intuitive Surgical Inc
|
566.98 | 205.74B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
228.45 | 65.11B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
94.14 | 46.26B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
233.10 | 34.51B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
91.65 | 18.19B | 3.90B | 392.30M | 288.10M | 1.95 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-08 | Iniziato | Lake Street | Buy |
| 2025-01-07 | Iniziato | Barclays | Overweight |
| 2025-01-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-01-07 | Iniziato | TD Cowen | Buy |
Anteris Technologies Global Corp Borsa (AVR) Ultime notizie
Anteris to Present at Healthcare Investor ConferencesTD Cowen and Barclays - TradingView
Anteris Technologies Global (NASDAQ:AVR) Trading 1.9% Higher – What’s Next? - Defense World
Anteris Technologies Global (NASDAQ:AVR) Trading 1.9% HigherWhat's Next? - MarketBeat
Anteris Technologies Secures Favorable ATO Tax Rulings - TipRanks
Anteris Technologies Announces ASX Quotation of Securities - TipRanks
Anteris Technologies Adjusts CDI and Common Stock Holdings - TipRanks
Market report: ASX falls 1.79% as market declines across all sectors - Proactive Investors USA
Head-To-Head Analysis: Anteris Technologies Global (NASDAQ:AVR) vs. Inogen (NASDAQ:INGN) - Defense World
Cantor Fitzgerald Estimates AVR FY2025 Earnings - Defense World
L1 Capital Pty Ltd Acquires Significant Stake in Anteris Technol - GuruFocus.com
FY2025 Earnings Forecast for AVR Issued By Cantor Fitzgerald - MarketBeat
Anteris Technologies Expands Public Offering with Additional Share Issuance - TipRanks
Anteris Technologies announces partial IPO over-allotment exercise - Investing.com
Anteris Technologies announces partial IPO over-allotment exercise By Investing.com - Investing.com Canada
Healthcare outlook 2025: healthcare and biotech to regain investor focus - Proactive financial news
Anteris Technologies Global Corp’s Quiet Period Set To End on January 22nd (NASDAQ:AVR) - Defense World
Anteris Technologies Announces Partial Over-Allotment Exercise and End of IPO Stabilisation - TipRanks
FY2024 Earnings Forecast for AVR Issued By Cantor Fitzgerald - MarketBeat
Anteris Technologies Global Corp. Rings the Opening Bell - Nasdaq
Anteris Technologies Global (NASDAQ:AVR) Coverage Initiated at Lake Street Capital - Defense World
TD Cowen Begins Coverage on Anteris Technologies Global (NASDAQ:AVR) - Defense World
Barclays Initiates Coverage on Anteris Technologies Global (NASDAQ:AVR) - Defense World
Cantor Fitzgerald Initiates Coverage on Anteris Technologies Global (NASDAQ:AVR) - Defense World
Anteris Technologies Adjusts Stock Positions Between ASX and Nasdaq - TipRanks
Healthcare sector: back in focus in 2025 - Proactive Investors USA
Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst - Benzinga
Anteris Technologies Global (NASDAQ:AVR) Now Covered by Analysts at TD Cowen - MarketBeat
This Coca-Cola Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Anteris Technologies Global (NASDAQ:AVR) Coverage Initiated by Analysts at Cantor Fitzgerald - MarketBeat
Cantor Fitzgerald starts Anteris stock with Overweight rating - Investing.com
Admedus Limited Announces Approval for First-In-Human Surgical Aortic Valve Replacement Trial of Proprietary ADAPT Single-Piece 3D Aortic Valve At the Leuven University Hospitals - Marketscreener.com
Anteris Technologies’ Bold Shift to U.S. Markets - MSN
Admedus Limited to Relocate Corporate Services Functions to Brisbane; Announces Executive Changes - Marketscreener.com
Heart valve developer Anteris launches IPO - MedTech Dive
Admedus Ltd : Admedus's CardioCel® Cleared for Sale in the US - Marketscreener.com
Anteris Technologies Redeems Convertible Notes - TipRanks
Anteris Technologies Announces New Director Appointment - TipRanks
Anteris Technologies Debuts on NASDAQ with IPO - MSN
Anteris Technologies Prepares for Stock Market Expansion - MSN
Anteris Completes Key Animal Study for EFS Submission - Marketscreener.com
Allied Healthcare Group Ltd : Allied reports no calcification from phase II CardioCel patients after 5 years - Marketscreener.com
Anteris Technologies Ltd Provides Data Update on First in Human Study of DurAVR THV Presented At New York Valves 2024 - Marketscreener.com
Anteris Technologies Announces Presentation of First-In-Human Data for its Novel TAVR Product, DurAVR™ at the 2022 Annual TCT Congress in Boston - Marketscreener.com
Admedus Limited Appoints Maja Mcguire as Company Secretary - Marketscreener.com
Anteris Submits Confidential Draft Registration Statement for Proposed US IPO - Marketscreener.com
Anteris Technologies Ltd Reports Successful Interim Results for the First-In-Human Trial - Marketscreener.com
US FDA Allows Manufacturing to Start at Anteris Technologies' Expanded Production Facility for DurAVR THV - Marketscreener.com
Anteris Technologies Ltd Announces FDA Allows Manufacturing to Begin At Expanded Facility - Marketscreener.com
Admedus Limited Announces Management Changes - Marketscreener.com
Anteris Technologies Global Corp. Announces Launch of U.S. Initial Public Offering - Marketscreener.com
Anteris Technologies Global Corp Azioni (AVR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.97%
1.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):